Smoking Cessation - Data, Analysis & Forecasts to 2023GMR Data Ltd. - April 10, 2013 - 101 Pages - SKU: GMR5160737 |
Pharmaceutical, Commercial & Strategic Developments in the Global Smoking Cessation Market 2013-2023
In April 2013 the US Food & Drug Agency (FDA) announced its plan to relax rules regarding the use and labelling of over-the-counter nicotine replacement therapies.
On April 1st 2013, FDA Commissioner Margaret A. Hamburg M.D. stated, “The agency heard from several public health groups that the labelling for OTC NRT products may stop consumers who are trying to quit smoking from using them. The FDA hopes the recommended changes ... read the full abstract
Since 1998, MarketResearch.com has provided companies with the business intelligence and research they need to make informed decisions.
We provide information on products, trends, regions, demographics, industries and companies from our collection of over 700 research publishers and 400,000 research reports.
About Us
We provide information on products, trends, regions, demographics, industries and companies from our collection of over 700 research publishers and 400,000 research reports.
About Us
